InnoStars, InnoStars

EIT Health rewards an innovative brain-training device

24th June 2020

EIT Health InnoStars, as a partner of Health Challenges Congress 2020 and Start-up Med Competition, recognised NeuroPlay, a Polish start-up. The team will be provided with the EIT Health mentoring to support the development of their solution for improving the cognitive functions of elderly patients.

NeuroPlay is a Polish start-up which supports cognitive capability retention and development of seniors (65+) by engaging them in training sessions involving an efficacy-proven, EEG-biofeedback method. This remote solution is available without leaving home and with no trained technician required to participate in the training sessions. This is the first certified medical device on the market that helps the elderly improve their cognitive ability through brain training. This way, the authors of the solution want to boost the quality of life, health and daily functioning of seniors.

The NeuroPlay team is currently starting clinical trials including a total of almost 200 patients and 2,000 training sessions. The study involves people who age physiologically as well as groups of patients with dementia and mild cognitive impairment (MCI).

One of EIT Health goals is to support breakthrough solutions which will promote healthy living and active ageing among European seniors and patients. InnoStars decided to reward Neuroplay with funding a special voucher for €2,000 to use in the EIT Health Mentoring and Coaching Network.

It’s great to recognise new promising solutions that can improve the treatment of brain disorders. We hope that this award will be the first step for NeuroPlay in their EIT Health journey, highlighted Mikołaj Gurdała, InnoStars Manager, Innovation Manager at EIT Health InnoStars.

Value-Based Healthcare at Health Challenges Congress

This fifth Health Challenges Congress (HCC), which was held online due to the COVID-19 pandemic, brought together the whole spectrum of healthcare stakeholders to address key health challenges. Besides looking at the challenges faced by specialists in particular fields of medicine, the Congress also addressed organisational and financial challenges that must be met by decision-makers shaping healthcare systems in Poland and other countries. The participants include eminent specialists representing several medical disciplines as well as representatives of the world of science, economy, business, finance, the insurance market, NGOs, politics, local government administration, media, and patients. InnoStars held also a panel discussion entitled “Value Based Healthcare – do we have any other solution?”, referring to the recently published EIT Health report “Implementing Value-Based Healthcare in Europe: Handbook for Pioneers”. More information about main key takeaways from the debate will be shared soon.

Ochre Bio closes €30M Series A funding round

Ochre Bio closes €30M Series A funding round

Learn more about their development

Find out more joins forces with La Roche-Posay joins forces with La Roche-Posay

Discover how the partnership will benefit patients

Find out more

Leuko closes €5M Series A round

Leuko closes €5M Series A round

Learn more about Leuko and its achievements

Find out more